Cell surface thermal proteome profiling tracks perturbations and drug targets on the plasma membrane

Mathias Kalxdorf(German Cancer Research Center), Marcus Bantscheff(Roche (Switzerland)), H. Christian Eberl(GlaxoSmithKline (Germany)), Isabelle Becher, Ina Günthner, Mikhail M. Savitski(European Molecular Biology Laboratory), Nils Kurzawa(Institute for Research in Biomedicine), Sascha Knecht(GlaxoSmithKline (Germany))
Nature Methods
January 1, 2021
10.1038/s41592-020-01022-1
Cited by 92

Related Papers

Mass-spectrometry-based draft of the human proteome
|Nature|2014|1.9k
Quantitative mass spectrometry in proteomics: a critical review
|Analytical and Bioanalytical Chemistry|2007|1.7k
Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia
|Nature|2011|1.5k
Tracking cancer drugs in living cells by thermal profiling of the proteome
|Science|2014|1.2k
Quantitative mass spectrometry in proteomics: critical review update from 2007 to the present
|Analytical and Bioanalytical Chemistry|2012|801